Trial Profile
A Randomized, Open-Label, Comparative, Multicenter Trial to Compare the Effects on Metabolic Parameters of Two NOMAC-E2 Batches (Pivotal Phase III and Commercial Batch) and a Monophasic COC Containing 150 microg LNG and 30 microg EE (Protocol No. P06447)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2012
Price :
$35
*
At a glance
- Drugs Estradiol/nomegestrol (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Pregnancy
- Focus Pharmacodynamics
- Sponsors Schering-Plough Research Institute
- 09 Jun 2011 New trial record